The Food and Drug Administration on Tuesday announced it approved Ingrezza (valbenazine) capsules to...

To reduce barriers to clozapine use, prescribers should collaborate with primary care physicians to ...

Patients with Alzheimer’s disease who take benzodiazepines are nearly 30% more likely to develop pne...

Young patients who have been diagnosed with first-episode psychosis (FEP) are much more likely to di...

Researchers have developed an updated screening scale for diagnosing adults with attention-deficit/h...

Patients who have a history of sexual trauma may be more likely to respond to interpersonal psychoth...

While more than 12% of youth report having experienced a hallucination, these hallucinations are oft...

Adjunctive vagus nerve stimulation (VNS) can lead to better five-year clinical outcomes in patients ...

The U.S. Supreme Court on March 28 reaffirmed that intellectual disability is a constitutional barri...